Premium
Death following ingestion of MDMA (ecstasy) and moclobemide
Author(s) -
Vuori Erkki,
Henry John A.,
Ojanperä Ilkka,
Nieminen Raija,
Savolainen Taru,
Wahlsten Pia,
Jäntti Matti
Publication year - 2003
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1046/j.1360-0443.2003.00292.x
Subject(s) - moclobemide , ecstasy , mdma , ingestion , hallucinogen , drug , medicine , serotonin syndrome , pharmacology , psychiatry , psychology , serotonin , antidepressant , serotonergic , anxiety , receptor
Four deaths following the ingestion of moclobemide and MDMA (‘ecstasy’) are described. The probable cause of death in each case was serotonin syndrome as a result of an interaction between the two drugs. As none of the victims had been prescribed moclobemide it seems that each had taken the drug to enhance the effects of MDMA, with fatal consequences. Warnings are needed against misinformed attempts to potentiate the pharmacological effects of illicit drugs.